A5026038975- Vaccine Coverage and Hesitancy
- Global Maternal and Child Health
- Organizational Learning and Leadership
- Escherichia coli research studies
- Human Resource Development and Performance Evaluation
- Emergency and Acute Care Studies
- Intimate Partner and Family Violence
- Influenza Virus Research Studies
- Maternal and Perinatal Health Interventions
- Evaluation and Performance Assessment
- Maternal and fetal healthcare
- Child Nutrition and Water Access
- Viral gastroenteritis research and epidemiology
- COVID-19 Impact on Reproduction
- Terrorism, Counterterrorism, and Political Violence
- HIV/AIDS Impact and Responses
Ghana Health Service
2024
New vaccines for pregnant women have recently been introduced in some high-income countries to protect infants early life. Implementing maternal immunisation (MI) successfully low- and middle-income will require planning adaptations health programs. To inform cost of MI delivery studies, we gathered perspectives from key stakeholders five (Bangladesh, Ghana, Kenya, Mozambique, Nepal) regarding system requirements, opportunities, challenges introducing new into routine
Shigella is the leading bacterial cause of diarrheal mortality in children and can long-term effects on growth development. No licensed vaccines currently exist but several promising candidates are development could be available next five years. Despite being a well-known public health target World Health Organization for decades, given current burden estimates competing preventable disease priorities low-income settings, whether availability an effective vaccine will lead to its...
Objectives Use of intrauterine balloon tamponades for refractory postpartum haemorrhage (PPH) management has triggered recent debate since effectiveness studies have yielded conflicting results. Implementation research is needed to identify factors influencing successful integration into maternal healthcare packages. The Ellavi uterine tamponade (UBT) (Ellavi) a new low-cost, preassembled device treating PPH. Design A mixed-methods, prospective, implementation study examining the adoption,...
New respiratory syncytial virus (RSV) maternal vaccines have begun roll out in some countries, with efforts progress to broaden access worldwide and shorten the timeline for low- middle-income countries (LMICs). Prior new immunization (MI) introductions, will need evaluate their capacity readiness successful introduction. The World Health Organization's Maternal Immunization Antenatal Care Situation Analysis (MIACSA) project (2016–2019) developed a checklist self-evaluate introduce vaccines....